Navigation Links
Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Date:4/8/2008

mpairs the person's ability to carry out their daily responsibilities because they are too tired or have trouble concentrating.

Insomnia has a variety of causes. It is often a symptom of some other disease or condition (e.g. life stress, psychiatric and medical disorders, or use of certain medications), but it can also be a distinct disorder. The prevalence of insomnia increases with age and is more common in women. Common symptoms of acute insomnia are sleepiness, negative mood and impairment of performance. Chronic insomnia is often associated with fatigue, mood changes, difficulty concentrating and impaired daytime functioning.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the continued development of APD125; the protocol, design, scope, enrollment, number, timing and other aspects of clinical trials of APD125; the timing of the results from the Phase 2b clinical trial of APD125 and expectations related to such results; the tolerability, side effects, safety profile, efficacy and the
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a ... of epilepsy, today announced it will participate in the 33 ... 14, 2015, in San Francisco . ... Officer, will speak at 11:00 AM Pacific Time.  A live ... on the Investor Relations link on the Cyberonics home page ...
(Date:12/22/2014)... , Dec, 22, 2014  Eiger BioPharmaceuticals ... 2a study of lonafarnib in patients with chronic ... conducted at the National Institutes of Health (NIH) ... .  The double-blinded, randomized, placebo-controlled, dose ascending study ... daily and 200 mg twice daily for 28 ...
(Date:12/19/2014)... WAYNE, N.J. , Dec. 19, 2014  In the Friday, ... , a 16-page supplement dedicated to Healthcare Information Technology (HIT) features ... innovation in Healthcare IT in partnership with several leading healthcare organizations. ... be distributed across several major metropolitan markets, such as ... Washington DC / Baltimore , Minneapolis ...
Breaking Medicine Technology:Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2
... Thousands of people with disabilities, their families, caregivers, seniors, ... Friday, August 26, through Sunday, August 28, 2011 at Reliant ... am to 5 pm, Saturday 10 am to 5 pm ... Expo has put together an impressive line-up of exhibits, workshops, ...
... 17, 2011 Former Congressman and PhRMA CEO Billy ... management company CaptureRx . He will also serve ... Tauzin will work on behalf of CaptureRx, its hospital ... partner with the company. He will add his voice ...
Cached Medicine Technology:Abilities Expo, the Nation's Largest Event for People With Disabilities and Their Caregivers, Is Coming to the Houston Area on August 26-28 2Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator 2
(Date:12/22/2014)... As part of a company-wide commitment ... San Diego and surrounding areas, Golden Care ... team with ongoing online training courses. , Online ... by Caregiverlist®. Caregiverlist® is “the premiere service ... reliable eldercare options, highest quality ratings and outstanding ...
(Date:12/22/2014)... 2014 Coral Gables is preparing to welcome ... Troopers, with its new clinic location set to open in ... hassle out of dealing with this common childhood parasite by ... two salon clinic locations in South Florida, or in the ... decision to expand developed naturally out of the demand for ...
(Date:12/22/2014)... SC (PRWEB) December 22, 2014 On ... was joined by Pastor Gordon Cashwell for an episode ... Deierlein asks Gordon, “Why is it so important to ... of Jesus?” Cashwell replies, “We all should respect who ... country was founded on Christian beliefs. That means that ...
(Date:12/22/2014)... Dec. 19, 2014 (HealthDay News) -- U.S. and state ... caramel apples that has killed at least four people ... should not eat any commercially produced, prepackaged caramel apples ... Disease Control and Prevention said in a news release. ... people had been infected with the outbreak strains of ...
(Date:12/22/2014)... NY (PRWEB) December 22, 2014 ... stronger than ever, having invested more than $5 ... service members, veterans and their families. , This ... nearly a dozen nonprofits, helping with: veteran entrepreneurship; ... scholarships; and life-coaches for severely injured veterans. , ...
Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Professional In-Home All-Natural Lice Removal Service Expands to Coral Gables and surrounding areas. 2Health News:My Positive Perspective Celebrates Christmas With an Event to Celebrate the Birthday of Jesus 2Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7
... OME ), the nation,s leading producer of Omega-3 fish ... of $12.1 million,($0.72 a share) for the fiscal year ... million ($0.19 a share) for the year ended December ... year ended December 31, 2007, the Company had revenues ...
... Omega 3 and Turmeric ... Supplement, ... introduce the latest addition to their family of joint,relief products, which can ... anti-inflammatory formula containing Omega 3 and,Turmeric for double strength joint relief., ...
... largely driven by new cases among gay, bisexual men, CDC ... seventh year in a row, rates of syphilis infection have ... gay and bisexual men, according to a new federal report. ... primary and secondary syphilis -- the earliest and most infectious ...
... The following,is being issued by the Foundation for ... consumer advocate will speak out against proposed legislation ... bars the sharing of private,medical information without a ... by deeming what amounts to marketing material to ...
... Pediatrics has been awarded a five-year, $2.1 million grant ... Development, part of the National Institutes of Health (NIH), ... members embark on research careers. , The grant renews ... resulted in the training of 26 UI clinician-scientists in ...
... an improvement in health-related quality of life, ... March 12 Naturopathic care is more,cost-effective than ... low-back pain, according to a study in the ... Medicine, a peer-reviewed,medical journal published by InnoVision Health ...
Cached Medicine News:Health News:Omega Protein Reports 2007 Results 2Health News:Omega Protein Reports 2007 Results 3Health News:Omega Protein Reports 2007 Results 4Health News:Omega Protein Reports 2007 Results 5Health News:The Makers of Conquer HA(TM) Launch All-Natural Double Strength Anti- Inflammatory Formula 2Health News:U.S. Syphilis Rate Grows for 7th Year in Row 2Health News:U.S. Syphilis Rate Grows for 7th Year in Row 3Health News:Consumer Advocate Speaks Out Against Bill Allowing Invasions of Medical Privacy; Author Received $21k from Bill Benefactors 2Health News:Consumer Advocate Speaks Out Against Bill Allowing Invasions of Medical Privacy; Author Received $21k from Bill Benefactors 3Health News:Consumer Advocate Speaks Out Against Bill Allowing Invasions of Medical Privacy; Author Received $21k from Bill Benefactors 4Health News:Consumer Advocate Speaks Out Against Bill Allowing Invasions of Medical Privacy; Author Received $21k from Bill Benefactors 5Health News:$2.1 million NIH grant advances U-Iowa child health research 2Health News:$2.1 million NIH grant advances U-Iowa child health research 3Health News:Study Finds Naturopathic Care for Chronic Low-Back Pain to be Efficacious, Cost-Effective 2
... these recommendations with the exceptional design and ... resulted in numerous improvements, such as:, ... holder for hassle-free storage , The system ... a flick of the lever, making transportation ...
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
... Diagnostics is a clinical reference ... treatment and monitoring of hemostatic ... a collaboration of four laboratory ... defined vision to deliver customizable ...
All-natural porcine collagen can be used in open or laparoscopic placement....
Medicine Products: